Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06602167 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Electroacupuncture Combined With Self-administered Acupressure for the Prevention of Capecitabine-Associated Hand-Foot Syndrome

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Secondary endpoints: details revised at 6 of 9 entriesv3
  2. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary endpoint revised
    • Start date changed from estimate of Sep 15, 2024 to Oct 8, 2024
    • Secondary endpoints: 7 to 9
    • Site details revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study hypothesizes that electroacupuncture combined with self-administered acupressure plus doctor-prescribed treatment is effective in preventing Hand-Foot Syndrome (HFS) caused by capecitabine. It aims to explore the effectiveness of this combined approach in preventing HFS in patients with malignant tumors undergoing oral capecitabine treatment. Further exploration of prevention and treatment methods may enhance the quality of life for patients during the treatment process.
Trial Details
NCT Number NCT06602167
Lead Sponsor Affiliated Hospital of Qinghai University
Conditions
(from sponsor)		 Capecitabine, Hand-foot Syndrome, Electroacupuncture, Self-administered Acupressure, Breast Cancer, Gastrointestinal Cancers
Related terms Breast Neoplasms, Gastrointestinal Neoplasms, Hand-Foot Syndrome
Enrollment 220 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov